Islets is a vital academic journal dedicated to advancing our understanding of the complex mechanisms underlying islet biology and its implications in health and disease. Published by Taylor & Francis Inc, this journal aims to serve as a premier platform for researchers, clinicians, and students engaged in the fields of Endocrinology, Diabetes, and Metabolism. With a focus on publishing high-quality research articles, reviews, and clinical studies, Islets seeks to contribute significantly to the ongoing dialogue in these critical areas of biomedical research. Boasting a Category Quartile of Q3 in both Endocrinology and Endocrinology, Diabetes and Metabolism, as well as relevant Scopus rankings that underscore its role in the research community, Islets provides an essential resource for those looking to stay informed and make impactful contributions to the field. While offering exclusive insights from 2009 to 2024, the journal encourages an open exchange of ideas that paves the way for future discoveries and advancements in islet research.

The International Journal of Cancer Management is a distinguished publication dedicated to advancing knowledge and research in the fields of cancer management, oncology, pharmacology, and radiology. Published by BRIEFLAND in the Netherlands, this journal serves as a vital resource for researchers, healthcare professionals, and students interested in the latest developments in cancer care and treatment strategies. With an ISSN of 2538-4422 and an E-ISSN of 2538-497X, the journal features a range of peer-reviewed articles that cover diverse aspects of cancer management, reflecting its commitment to high-quality, impactful research. The journal ranks in the Q4 category for Cancer Research and Oncology and Q3 for both Pharmacology and Surgery in 2023, signifying its growing influence in the scientific community. Through its open access format, the International Journal of Cancer Management ensures that critical research findings are accessible to all, promoting collaboration and innovation in the battle against cancer. Researchers looking to share their findings or learn more about current trends will find this journal an invaluable addition to their professional toolkit.

Pancreatology is a prestigious journal published by ELSEVIER, focusing on the multifaceted disciplines of endocrinology, diabetes, gastroenterology, and hepatology since its inception in 2001. With an impressive Q1 ranking in multiple categories, including Endocrinology and Gastroenterology, Pancreatology stands out as a critical platform for disseminating peer-reviewed research that contributes to the evolving understanding of pancreatic diseases and associated metabolic disorders. This journal has gained significant recognition in the academic community, underscored by its robust Scopus rankings, positioning it favorably among its peers. While it currently does not offer open access, Pancreatology remains committed to advancing knowledge through high-quality publications and fostering innovation in clinical practice and research. Researchers, professionals, and students are invited to engage with the cutting-edge findings within its pages, which are essential for driving progress in this essential area of medicine.

The United European Gastroenterology Journal, published by John Wiley & Sons Ltd, is a leading publication in the fields of gastroenterology and oncology, boasting a distinguished Q1 ranking in both categories for 2023. With an ISSN of 2050-6406 and an E-ISSN of 2050-6414, this journal serves as a vital platform for disseminating cutting-edge research and innovative practices from 2013 to 2024, supporting the advancement of knowledge in gastrointestinal health and cancer treatment. With a commendable Scopus Rank of 14th out of 167 in gastroenterology and 54th out of 404 in oncology, it emphasizes the significance of impactful research in these critical areas. While currently not an open-access journal, it remains a vital resource for researchers, professionals, and students seeking comprehensive insights and evidence-based approaches to improve patient care and clinical outcomes. The United European Gastroenterology Journal is committed to bridging the gap between research and practice, making it an essential reference for those dedicated to the fields of gastroenterology and oncology.

Asian Biomedicine, published by WALTER DE GRUYTER GMBH, serves as a crucial platform for disseminating pioneering research in the field of biomedical sciences. Established in 2008, this journal has carved its niche in the landscape of academic publishing, concentrating on a diverse array of topics within biochemistry, genetics, and molecular biology, as well as medicine. Though it currently holds a Q4 ranking in its category, it is dedicated to fostering academic discussions and advancing knowledge among researchers, professionals, and students alike. While the journal features a variety of access options, it is committed to ensuring that its content remains relevant and impactful, with an emphasis on the latest developments and research trends. The editorial board encourages submissions that address pressing biomedical issues, thus empowering contributors to engage meaningfully with the scientific community. With a broad international scope and a focus on quality, Asian Biomedicine is poised to play an increasingly important role in the advancement of biomedical research in Asia and beyond.

The Journal of Clinical Urology, published by SAGE Publications Ltd, is a prominent academic platform dedicated to advancing the field of urology and surgical medicine. With an ISSN of 2051-4158 and an E-ISSN of 2051-4166, this journal has been pivotal in disseminating cutting-edge research since its inception in 2008 and is set to continue through 2024. Although categorized in the Q4 quartile for both Surgery and Urology, and positioned in the 24th and 22nd percentiles respectively according to Scopus rankings, the journal remains an essential resource for professionals, researchers, and students who seek to understand clinical developments and innovative practices in urological surgery. While the journal does not operate under an Open Access model, it provides critical insights and valuable findings that significantly impact healthcare practices and patient outcomes in the urology field.

The Breast Journal, published by Wiley-Hindawi, is a distinguished Open Access journal dedicated to the fields of internal medicine, oncology, and surgery with a particular focus on breast health and disease. Since its inception in 1995, the journal has become an essential resource for researchers and clinicians, facilitating the dissemination of high-quality research and innovative clinical practices. With an impact factor reflecting robust scholarly influence and a ranking in the Q3 quartile for both internal medicine and oncology, as well as Q2 in surgery, it showcases significant contributions that advance knowledge and improve patient outcomes. Offering unparalleled access to its articles, The Breast Journal aims to support a global audience in exploring the multifaceted challenges and breakthroughs in breast-related health, making it a vital platform for shared learning and scientific discourse.

Journal of Pancreatology, published by Lippincott Williams & Wilkins, serves as a vital resource in the fields of Endocrinology, Diabetes and Metabolism, and Hepatology. This Open Access journal, established to disseminate cutting-edge research and advancements in pancreatic health, has witnessed a substantial rise since its inception in 2018, with converged publications spanning through 2024. Although currently ranked in the Q3 category across multiple disciplines, the journal continually seeks to elevate the discourse around pancreatic diseases and endocrine functions through high-quality articles and comprehensive studies. Researchers, professionals, and students alike will find valuable insights that can drive future investigations and clinical applications. The journal is accessible from anywhere in the world, ensuring that critical knowledge in this important field reaches a wide audience without barriers. Explore the Journal of Pancreatology to stay at the forefront of pancreatic research and contribute to meaningful developments in medical science.

Clinical and Experimental Gastroenterology is a prestigious Open Access journal published by DOVE MEDICAL PRESS LTD, dedicated to advancing the field of gastroenterology through rigorous research and innovative insights. With its ISSN 1178-7023, the journal has established a significant presence since its inception in 2008 and has been actively contributing to the academic landscape from New Zealand. The journal has attained a commendable Q2 rank in the Gastroenterology category as of 2023, placing it in the upper-tier percentile of similar journals. It currently ranks #57 out of 167 in the Scopus database, highlighting its relevance and impact in the field at the 66th percentile. Encompassing a wide range of topics within gastroenterology, the journal aims to foster discussion and disseminate findings that enhance clinical practices and patient care. Researchers, healthcare professionals, and students alike will find this journal an invaluable resource for cutting-edge research and developments in gastrointestinal health.

PANCREAS, published by Lippincott Williams & Wilkins, is a preeminent journal dedicated to advancing the field of endocrinology, diabetes, hepatology, and internal medicine. With an ISSN of 0885-3177 and E-ISSN of 1536-4828, this journal aims to disseminate high-quality research findings and clinical insights that are pivotal for professionals in these areas. The journal has established itself with an impressive Q2 ranking across multiple categories in the 2023 rankings, including endocrinology, diabetes and metabolism, hepatology, and internal medicine. Although it offers no open access options, the content is meticulously curated to enrich the knowledge base of researchers and practitioners. The Scopus rankings further underscore its influence, ranking #64 in Internal Medicine and #36 in Hepatology, reflecting its commitment to scholarly excellence. Based in the United States at Two Commerce Square, 2001 Market St, Philadelphia, PA 19103, PANCREAS serves as a central hub for innovative research from 1986 to 2024, making it an essential resource for those engaged in these rapidly evolving fields.